FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154270538> ?p ?o ?g. }

• W2154270538 endingPage "629" @default.
• W2154270538 startingPage "615" @default.
• W2154270538 abstract "6-Fluoro-3-hydroxy-2-pyrazinecarboxamide (T-705) is a novel antiviral compound with broad activity against influenza virus and diverse RNA viruses. Its active metabolite, T-705-ribose-5'-triphosphate (T-705-RTP), is recognized by influenza virus RNA polymerase as a substrate competing with GTP, giving inhibition of viral RNA synthesis and lethal virus mutagenesis. Which enzymes perform the activation of T-705 is unknown. We here demonstrate that human hypoxanthine guanine phosphoribosyltransferase (HGPRT) converts T-705 into its ribose-5'-monophosphate (RMP) prior to formation of T-705-RTP. The anti-influenza virus activity of T-705 and T-1105 (3-hydroxy-2-pyrazinecarboxamide; the analog lacking the 6-fluoro atom) was lost in HGPRT-deficient Madin-Darby canine kidney cells. This HGPRT dependency was confirmed in human embryonic kidney 293T cells undergoing HGPRT-specific gene knockdown followed by influenza virus ribonucleoprotein reconstitution. Knockdown for adenine phosphoribosyltransferase (APRT) or nicotinamide phosphoribosyltransferase did not change the antiviral activity of T-705 and T-1105. Enzymatic assays showed that T-705 and T-1105 are poor substrates for human HGPRT having Km(app) values of 6.4 and 4.1 mM, respectively. Formation of the RMP metabolites by APRT was negligible, and so was the formation of the ribosylated metabolites by human purine nucleoside phosphorylase. Phosphoribosylation and antiviral activity of the 2-pyrazinecarboxamide derivatives was shown to require the presence of the 3-hydroxyl but not the 6-fluoro substituent. The crystal structure of T-705-RMP in complex with human HGPRT showed how this compound binds in the active site. Since conversion of T-705 by HGPRT appears to be inefficient, T-705-RMP prodrugs may be designed to increase the antiviral potency of this new antiviral agent." @default.
• W2154270538 created "2016-06-24" @default.
• W2154270538 creator A5000300534 @default.
• W2154270538 creator A5035589253 @default.
• W2154270538 creator A5038319371 @default.
• W2154270538 creator A5072840045 @default.
• W2154270538 creator A5075935485 @default.
• W2154270538 creator A5079853523 @default.
• W2154270538 creator A5081640914 @default.
• W2154270538 date "2013-08-01" @default.
• W2154270538 modified "2023-10-02" @default.
• W2154270538 title "Role of Human Hypoxanthine Guanine Phosphoribosyltransferase in Activation of the Antiviral Agent T-705 (Favipiravir)" @default.
• W2154270538 cites W1515293536 @default.
• W2154270538 cites W1979606430 @default.
• W2154270538 cites W1982471331 @default.
• W2154270538 cites W1988581728 @default.
• W2154270538 cites W1997921949 @default.
• W2154270538 cites W2000970445 @default.
• W2154270538 cites W2018928802 @default.
• W2154270538 cites W2023016206 @default.
• W2154270538 cites W2038007589 @default.
• W2154270538 cites W2039941020 @default.
• W2154270538 cites W2047908801 @default.
• W2154270538 cites W2050169388 @default.
• W2154270538 cites W2055349955 @default.
• W2154270538 cites W2058203122 @default.
• W2154270538 cites W2071506940 @default.
• W2154270538 cites W2072369647 @default.
• W2154270538 cites W2072621169 @default.
• W2154270538 cites W2074824522 @default.
• W2154270538 cites W2078368610 @default.
• W2154270538 cites W2080287563 @default.
• W2154270538 cites W2081763756 @default.
• W2154270538 cites W2082341895 @default.
• W2154270538 cites W2091527885 @default.
• W2154270538 cites W2092079765 @default.
• W2154270538 cites W2098401378 @default.
• W2154270538 cites W2103556278 @default.
• W2154270538 cites W2103815049 @default.
• W2154270538 cites W2107667230 @default.
• W2154270538 cites W2108367829 @default.
• W2154270538 cites W2112481771 @default.
• W2154270538 cites W2114367386 @default.
• W2154270538 cites W2118217493 @default.
• W2154270538 cites W2122456305 @default.
• W2154270538 cites W2124026197 @default.
• W2154270538 cites W2125529503 @default.
• W2154270538 cites W2126448881 @default.
• W2154270538 cites W2129876916 @default.
• W2154270538 cites W2138274210 @default.
• W2154270538 cites W2140965090 @default.
• W2154270538 cites W2149251191 @default.
• W2154270538 cites W2153074293 @default.
• W2154270538 cites W2153568159 @default.
• W2154270538 cites W2155335707 @default.
• W2154270538 cites W2159207697 @default.
• W2154270538 cites W2163341755 @default.
• W2154270538 cites W2166596830 @default.
• W2154270538 cites W2180229411 @default.
• W2154270538 cites W3119363926 @default.
• W2154270538 cites W4248872320 @default.
• W2154270538 doi "https://doi.org/10.1124/mol.113.087247" @default.
• W2154270538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23907213" @default.
• W2154270538 hasPublicationYear "2013" @default.
• W2154270538 type Work @default.
• W2154270538 sameAs 2154270538 @default.
• W2154270538 citedByCount "85" @default.
• W2154270538 countsByYear W21542705382013 @default.
• W2154270538 countsByYear W21542705382014 @default.
• W2154270538 countsByYear W21542705382015 @default.
• W2154270538 countsByYear W21542705382016 @default.
• W2154270538 countsByYear W21542705382017 @default.
• W2154270538 countsByYear W21542705382018 @default.
• W2154270538 countsByYear W21542705382019 @default.
• W2154270538 countsByYear W21542705382020 @default.
• W2154270538 countsByYear W21542705382021 @default.
• W2154270538 countsByYear W21542705382022 @default.
• W2154270538 countsByYear W21542705382023 @default.
• W2154270538 crossrefType "journal-article" @default.
• W2154270538 hasAuthorship W2154270538A5000300534 @default.
• W2154270538 hasAuthorship W2154270538A5035589253 @default.
• W2154270538 hasAuthorship W2154270538A5038319371 @default.
• W2154270538 hasAuthorship W2154270538A5072840045 @default.
• W2154270538 hasAuthorship W2154270538A5075935485 @default.
• W2154270538 hasAuthorship W2154270538A5079853523 @default.
• W2154270538 hasAuthorship W2154270538A5081640914 @default.
• W2154270538 hasConcept C104317684 @default.
• W2154270538 hasConcept C142724271 @default.
• W2154270538 hasConcept C143065580 @default.
• W2154270538 hasConcept C153911025 @default.
• W2154270538 hasConcept C159047783 @default.
• W2154270538 hasConcept C185592680 @default.
• W2154270538 hasConcept C2777991568 @default.
• W2154270538 hasConcept C2779134260 @default.
• W2154270538 hasConcept C2779772310 @default.
• W2154270538 hasConcept C3008058167 @default.
• W2154270538 hasConcept C524204448 @default.
• W2154270538 hasConcept C55493867 @default.

• next